![](/img/cover-not-exists.png)
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation
Venditti, A, Maurillo, L, Buccisano, F, Del Poeta, G, Mazzone, C, Tamburini, A, Del Principe, M I, Consalvo, M I, De Fabritiis, P, Cudillo, LVolume:
18
Year:
2004
Pages:
1
DOI:
10.1038/sj.leu.2403278
File:
PDF, 27 KB
2004